Måndag 2 Juni | 16:57:03 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2025-11-27 08:30 Kvartalsrapport 2025-Q3
2025-08-28 08:30 Kvartalsrapport 2025-Q2
2025-05-28 - Årsstämma
2025-04-25 - Kvartalsrapport 2025-Q1
2025-04-23 - Extra Bolagsstämma 2025
2025-04-11 - X-dag ordinarie utdelning CURAS 0.00 DKK
2025-02-27 - Bokslutskommuniké 2024
2024-11-21 - Kvartalsrapport 2024-Q3
2024-08-22 - Kvartalsrapport 2024-Q2
2024-07-02 - Extra Bolagsstämma 2024
2024-05-23 - Kvartalsrapport 2024-Q1
2024-03-22 - X-dag ordinarie utdelning CURAS 0.00 DKK
2024-03-21 - Årsstämma
2024-02-22 - Bokslutskommuniké 2023
2023-11-23 - Kvartalsrapport 2023-Q3
2023-08-24 - Kvartalsrapport 2023-Q2
2023-05-25 - Kvartalsrapport 2023-Q1
2023-03-31 - X-dag ordinarie utdelning CURAS 0.00 DKK
2023-03-30 - Årsstämma
2023-02-23 - Bokslutskommuniké 2022
2022-11-24 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-24 - Kvartalsrapport 2022-Q1
2022-04-27 - Årsstämma
2022-03-25 - X-dag ordinarie utdelning CURAS 0.00 DKK
2022-02-24 - Bokslutskommuniké 2021
2021-11-25 - Kvartalsrapport 2021-Q3
2021-08-24 - Kvartalsrapport 2021-Q2
2021-06-01 - Extra Bolagsstämma 2021
2021-05-20 - Kvartalsrapport 2021-Q1
2021-03-26 - X-dag ordinarie utdelning CURAS 0.00 DKK
2021-03-25 - Årsstämma
2021-02-24 - Bokslutskommuniké 2020
2020-11-30 - Kvartalsrapport 2020-Q3

Beskrivning

LandDanmark
ListaSpotlight DK
SektorHälsovård
IndustriMedicinteknik
Curasight är verksamt inom läkemedelsbranschen. Bolaget är specialiserat inom utveckling av teknologiska produkter. Produktportföljen är bred och har sin huvudsakliga fokus på utveckling av produkter inom området Positron Emissions Tomography (PET). Verksamheten drivs med störst närvaro inom Skandinavien. Curasight har sitt huvudkontor i Köpenhamn.
2025-05-28 14:26:00

Copenhagen, Denmark, 28 May 2025 - today Curasight A/S ("Curasight" or the "Company" - TICKER: CURAS) held its Annual General Meeting at the office of DLA Piper Denmark, Oslo Plads 2, 2100 Copenhagen OE, Denmark

Today, the shareholders in Curasight passed the following resolutions at the Annual General Meeting in accordance with the agenda:

1. The Board of Directors' report on the Company's activities in the past financial year

The general meeting took note of the Board of Directors' report on the Company's activities in 2024.

2. Presentation and approval of the annual report

The general meeting adopted the Company's annual report for 2024 unanimously with all votes represented at the general meeting.

3. Resolution on appropriation of profit or covering of loss as recorded in the adopted annual report

The general meeting adopted the proposal to carry forward the result for 2024 to the next year according to the adopted annual report for 2024 with all votes represented at the general meeting.

4. Election of members to the Board of Directors

The general meeting re-elected Kirsten Aarup Drejer, Lars Trolle, Charlotte Vedel, Andreas Kjær, and Ulrich Krasilnikoff as members of the Board of Directors with consent of all votes represented at the general meeting.

5. Election of auditor

PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab was re-elected as the Company's auditor with consent of all votes represented at the general meeting.

6. Proposal from the Board of Director or the shareholders

6.1 Incentive Programs

a.  Authorisations to issue warrants (Incentive Program for the Board of Directors, the Executive Management and other Key Employees

A proposal from the Board of Directors to authorise the Board of Directors to issue warrants to members of the Board of Directors, to the Executive Board and other Key Employees was unanimously adopted with all votes represented at the general meeting. Consequently, the Company's Articles of Association will be updated to incorporate the following new section 5.2.7:

"The Company's board of directors is authorised, pursuant to s. 155 of the Danish Companies Act, cf. s. 169 thereof, in one or several instances, to issue up to a total of 7,100,000 warrants to members of the board of directors, the Executive Management and other Key Employees ("Participants")  which will entitle the Participants to subscribe for up to a total of nominal DKK 355,000 shares in the Company (corresponding to 10% of the Company's share capital after the expected capital increase) without pre-emption rights for the existing shareholders at a subscription price and allocation determined by the board of directors, provided, however, that the price may not be lower than the market price on the date of the resolution. The market value shall be determined based on the average share price according to Spotlight's official listed share price for the Company's shares during five trading days preceding the date at which allocation of the warrant occurs, or such other price that the Company's board of directors is more reflective of the market price of the shares. The Company's board of directors is also authorised to carry out any related share capital increases, in one or several instances, up to a total of nominally DKK 355,000. The authorization is valid until 28 May 2030. Shares issued pursuant to the authorization in this clause 5.2.7. must be paid up in full, be negotiable instruments, be registered by name and be registered by the name of shareholders in the Company's shareholders' register. The same restrictions on transferability as those applying to the existing shares apply and no shareholder shall be obligated to have the shares redeemed partly or in full. Furthermore, the Company's board of directors is authorised to reuse or reissue lapsed and unexercised warrants, if any, provided that the reuse or reissue occurs under the terms set out in this authorisation."

6.2 Authorisation to the chairman of the meeting

The general meeting adopted a resolution to authorise the chairman of the meeting Ulrik Bangsbo Hansen to apply for registration of the resolutions passed and to make certain amendments, if necessary.

***

The Company's new articles of association will be published on the Company's website once they have been registered with the Danish Business Authority, and likewise, the minutes of the Annual General Meeting will also be made available on the website.

At a board meeting held immediately after the Annual General Meeting, Kirsten Drejer was re-elected as chairman and Lars Trolle vice-chairman of the Board of Directors.